Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 2, 2009, Pages

  Pini, Maria ^a   Gove, Melissa E ^a   Fayad, Raja ^a   Cabay, Robert J ^a   Fantuzzi, Giamila ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adipocytes; Colon; Cytokines; Inflammation

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMYLOID A PROTEIN; CD3 ANTIBODY; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 10; MONOCLONAL ANTIBODY CD28;

ANIMAL EXPERIMENT; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADIPONECTIN; AGE FACTORS; AGING; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE DENSITY; CELLS, CULTURED; COLITIS; DISEASE PROGRESSION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LEPTIN; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59449109650     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90593.2008     Document Type: Article

References (32)

1. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020, 1996.
2. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11: 648-656, 1999.
3. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241-251, 1996.
4. De Beer FC, Mallya RK, Fagan EA, Lanham JG, Hughes GR, Pepys MB. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2: 231-234, 1982.
5. De Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine 12: 1337-1347, 2000.
6. Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801, 2004.
7. Ealey KN, Kaludjerovic J, Archer MC, Ward WE. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) 233: 1546-1553, 2008.
8. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121: 326-330, 2008.
9. Fantuzzi G. Adipose tissue, adipokines, inflammation. J Allergy Clin Immunol 115: 911-919, 2005.
10. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132: 601-614, 2007.
11. Garaulet M, Hernández-Morante JJ, de Heredia FP, Tebar FJ. Adi-ponectin, the controversial hormone. Public Health Nutr 10: 1145-1150, 2007.
12. Ho AS, Moore KW. Interleukin-10 and its receptor. Ther Immunol 1: 173-185, 1994.
13. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792, 2006.
14. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 300: 1523-1531, 2008.
15. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 2586325866, 2002.
16. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6: 55-68, 2007.
17. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
18. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3: 716-724, 2007.
19. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33: 646-651, 2003.
20. Liao W, Yu C, Wen J, Jia W, Li G, Ke Y, Zhao S, Campell W. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol Cell 2008 [Epub ahead of print].
21. Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131: 853-861, 2006.
22. Ogunwobi OO, Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 134: 105-113,2006.
23. Paul G, Schaffler A, Neumeier M, Furst A, Bataillle F, Buechler C, Muller-Ladner U, Scholmerich J, Rogler G, Herfarth H. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12: 471-477, 2006.
24. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, Amor B, Couturier D. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 5: 156-160, 1995.
25. Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 14: 390-400, 2008.
26. - mice. J Immunol 171: 1401-1406, 2003.
27. Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40: 115-120, 2007.
28. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 179: 5483-5492, 2007.
29. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55: 426-431, 2006.
30. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 1834118347, 2005.
31. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59: 1073-1083, 2007.
32. Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, Funahashi T, Ito T, Nezu R, Tsutsui S, Miyagawa JI, Tamura S, Matsuzawa Y, Shimomura I, Shinomura Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 54: 789-796, 2005.